Kasance a kan abubuwan da ke faruwa a duniya a abinci, noma, fasahar yanayi da saka hannun jari tare da manyan labarai da bincike na masana'antu.
A halin yanzu, sunadaran recombinant yawanci suna samar da su ta hanyar ƙananan ƙwayoyin cuta a cikin manyan injiniyoyin ƙarfe. Amma kwari na iya zama mafi wayo, ƙarin masu ba da tattalin arziƙi, in ji FlyBlast na tushen Antwerp, wanda ke canza kwayoyin baƙar fata kwari don samar da insulin da sauran sunadarai masu mahimmanci.
Amma shin akwai haɗari ga dabarun farko na kamfani na kai hari ga masana'antar nama mai tasowa da tsabar kuɗi?
AgFunderNews (AFN) ta sami ganawa da wanda ya kafa kuma Shugaba Johan Jacobs (JJ) a taron Fasaha na Abinci na gaba a Landan don ƙarin koyo…
DD: A FlyBlast, mun canza ta hanyar jinsin sojan baƙar fata tashi don samar da insulin ɗan adam da sauran sunadaran da ke sake haɗawa, da kuma abubuwan haɓaka musamman waɗanda aka tsara musamman don shuka nama (amfani da waɗannan sunadaran sunadarai masu tsada a cikin kafofin watsa labarai na al'adun sel).
Molecules kamar insulin, transferrin, IGF1, FGF2 da EGF suna lissafin kashi 85% na farashin matsakaicin al'ada. Ta hanyar samar da waɗannan ƙwayoyin halittu masu yawa a cikin wuraren canza yanayin ƙwayoyin kwari, za mu iya rage farashin su da kashi 95% kuma mu shawo kan wannan ƙalubale.
Babban fa'idar sojan baƙar fata ta tashi [a kan ƙwayoyin cuta da aka gyara a matsayin hanyar samar da irin waɗannan sunadaran] shine zaku iya girma sojan baƙar fata a sikeli kuma a farashi mai rahusa saboda masana'antar gabaɗaya ta haɓaka canjin halittu ta samfuran zuwa sunadarai na kwari. da lipids. Muna haɓaka matakin fasaha da riba ne kawai saboda ƙimar waɗannan ƙwayoyin cuta suna da yawa.
Kudin babban birnin kasar [na bayyana insulin a cikin kudajin sojan baƙar fata] ya bambanta da [farashin daidaitaccen fermentation ta amfani da ƙananan ƙwayoyin cuta], kuma farashin babban birnin yana rufe da samfuran kwari na yau da kullun. Wata hanyar samun kudaden shiga ne a kan duk wannan. Amma kuma dole ne ku yi la'akari da cewa kwayoyin da muke yi niyya takamaiman sunadaran dabbobi ne. Yana da sauƙin samar da kwayoyin dabba a cikin dabbobi fiye da yisti ko kwayoyin cuta.
Misali, a cikin binciken yuwuwar mun fara duba ko kwari suna da hanyar insulin. Amsar ita ce eh. Kwayoyin kwarin suna kama da insulin mutum ko kaza, don haka tambayar kwari don samar da insulin ɗan adam yana da sauƙi fiye da tambayar ƙwayoyin cuta ko tsire-tsire, waɗanda ba su da wannan hanyar.
JJ: Muna mai da hankali kan nama mai al'ada, wanda kasuwa ce da har yanzu tana buƙatar haɓakawa, don haka akwai haɗari. Amma tunda biyu daga cikin wadanda suka kafa nawa suka fito daga waccan kasuwa (wasu mambobin kungiyar FlyBlast da yawa sun yi aiki a farawar mai zaman lafiya na Nama na tushen Antwerp, wanda mai shi Steakholder Foods ya shafe a bara), mun yi imani muna da dabarun. don ganin hakan ta faru. Wannan yana ɗaya daga cikin maɓallan.
Naman al'ada zai kasance a ƙarshe. Tabbas zai faru. Tambayar ita ce yaushe, kuma wannan tambaya ce mai mahimmanci ga masu zuba jarinmu, saboda suna buƙatar riba a cikin lokaci mai dacewa. Don haka muna duban sauran kasuwanni. Mun zaɓi insulin a matsayin samfurinmu na farko saboda kasuwa don maye gurbin ta bayyana. Insulin mutum ne, yana da arha, yana da girma, don haka akwai kasuwa mai yawa na ciwon sukari.
Amma a zahiri, dandalin fasahar mu babban dandali ne… A kan dandalin fasahar mu, zamu iya samar da mafi yawan kwayoyin halittar dabba, sunadarai, har ma da enzymes.
Muna ba da sabis na haɓaka kwayoyin halitta nau'i biyu: muna gabatar da sabbin kwayoyin halitta gaba ɗaya a cikin DNA ɗin sojan baƙar fata, yana ba shi damar bayyana ƙwayoyin da ba su wanzu a cikin wannan nau'in, kamar insulin ɗan adam. Amma kuma za mu iya wuce gona da iri ko murkushe kwayoyin halittar da ke wanzuwa a cikin nau'in DNA na daji don canza kaddarorin kamar abun ciki na furotin, bayanin martabar amino acid, ko abun da ke tattare da kitse (ta hanyar yarjejeniyar lasisi tare da manoma/masu sarrafa kwari).
DD: Wannan tambaya ce mai kyau, amma guda biyu daga cikin wadanda suka kafa nama suna cikin masana'antar nama, kuma sun yi imanin cewa [neman sinadarai masu rahusa irin su insulin] shine babbar matsala a masana'antar, kuma masana'antar tana da babban tasiri a kan yanayin.
Tabbas, muna kuma duba kasuwar magunguna ta mutum da kasuwar ciwon sukari, amma muna buƙatar babban jirgin ruwa don hakan saboda kawai batun samun izinin doka, kuna buƙatar dala miliyan 10 don yin takaddun, sannan kuna buƙatar yin aikin. tabbas kuna da madaidaicin kwayoyin halitta a daidaitaccen tsarki, da sauransu. Za mu ɗauki matakai da yawa, kuma idan muka isa wani matsayi na tabbatarwa, za mu iya tara jari don kasuwar biopharma.
J: Duk game da scaling ne. Na gudanar da wani kamfanin noman kwari [Millibeter, wanda AgriProtein [yanzu ya lalace] ya samu a cikin 2019 na tsawon shekaru 10. Don haka mun kalli kwari daban-daban, kuma mabuɗin shine yadda za a haɓaka samar da dogaro da dogaro da rahusa, kuma kamfanoni da yawa sun ƙare tare da kuda na soja baƙar fata ko tsutsotsin abinci. Eh, tabbas, zaku iya shuka ƙudaje na 'ya'yan itace, amma da gaske yana da wahala a shuka su da yawa cikin arha kuma abin dogaro, kuma wasu tsire-tsire na iya samar da ton 10 na ƙwayoyin cuta a rana.
JJ: Don haka sauran samfuran kwari, sunadaran kwari, lipids na kwari, da dai sauransu, ana iya amfani da su ta hanyar fasaha a cikin sarkar darajar kwari ta al'ada, amma a wasu wuraren, saboda samfur ne da aka canza ta kwayoyin halitta, ba za a yarda da shi azaman abincin dabbobi ba.
Koyaya, akwai aikace-aikacen fasaha da yawa a waje da sarkar abinci waɗanda zasu iya amfani da furotin da lipids. Misali, idan kuna samar da man shafawa na masana'antu akan sikelin masana'antu, ba komai ko lipid din ya fito ne daga tushen da aka gyara ta kwayoyin halitta.
Dangane da taki [najasar kwari], dole ne mu yi taka-tsan-tsan wajen safarar ta zuwa gonaki domin tana dauke da alamomin GMOs, don haka sai mu mayar da shi zuwa biochar.
DD: A cikin shekara guda… muna da tsayayyen layin kiwo wanda ke bayyana insulin ɗan adam a cikin yawan amfanin ƙasa. Yanzu muna buƙatar cire kwayoyin halitta kuma mu samar da samfurori ga abokan cinikinmu, sannan muyi aiki tare da abokan ciniki akan abin da kwayoyin da suke bukata na gaba.
Lokacin aikawa: Dec-25-2024